Published in Acta Otorhinolaryngol Ital on December 01, 2009
Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the "volcanic factor". Front Endocrinol (Lausanne) (2013) 0.85
Occult papillary thyroid carcinoma metastasis to the sacrum and the skull: an unusual presentation. Case Rep Med (2014) 0.80
Occult thyroid carcinoma: a rare case report and review of literature. Int J Clin Exp Pathol (2014) 0.77
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev (2007) 5.21
Papillary and follicular thyroid carcinoma. N Engl J Med (1998) 4.95
Extent of surgery affects survival for papillary thyroid cancer. Ann Surg (2007) 4.73
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab (2005) 4.39
Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med (2005) 4.12
Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer (1985) 3.69
Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet (2009) 3.46
THE SURGICAL TREATMENT OF CYSTS OF THE THYROGLOSSAL TRACT. Ann Surg (1920) 3.45
An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery (1988) 3.27
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 3.23
Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ (1992) 2.99
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery (1987) 2.42
Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab (2006) 2.31
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab (2007) 1.95
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2006) 1.77
Management of well-differentiated thyroid carcinoma presenting within a thyroglossal duct cyst. J Surg Oncol (2002) 1.73
Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg (2006) 1.71
Geographic pathology of occult thyroid carcinomas. Cancer (1975) 1.71
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol (2008) 1.65
Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J (2004) 1.63
Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J (2008) 1.53
Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. Thyroid (2000) 1.52
A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control (1999) 1.50
Pathology and genetics of thyroid carcinoma. J Surg Oncol (2006) 1.45
Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer. J Clin Endocrinol Metab (2006) 1.43
Epidemiology and primary prevention of thyroid cancer. Thyroid (2002) 1.41
S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? J Mol Med (Berl) (2008) 1.36
Thyroglossal duct carcinoma: a rational approach to management. Laryngoscope (1998) 1.34
Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta (1998) 1.31
Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer (1990) 1.25
Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Oncology (2004) 1.21
Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf) (2006) 1.20
Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules: comparison in efficacy according to nodule size. Thyroid (2009) 1.18
Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett (2008) 1.18
15 years after Chernobyl: new evidence of thyroid cancer. Lancet (2001) 1.17
Thyroglossal duct carcinoma: a large case series. Ann Otol Rhinol Laryngol (2001) 1.17
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma. J Clin Endocrinol Metab (2007) 1.16
Lingual thyroid carcinoma: a case report and review of the literature. Thyroid (2001) 1.14
A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol (1996) 1.12
The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol (2000) 1.11
Survival impact of treatment options for papillary microcarcinoma of the thyroid. Laryngoscope (2009) 1.11
Ectopic thyroid in the retroesophageal superior mediastinum. Otolaryngol Head Neck Surg (1988) 1.10
TNM classification of thyroid carcinoma. World J Surg (2007) 1.10
Occult thyroid carcinoma at autopsy in Malmö, Sweden. Cancer (1981) 1.10
High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts. Ann Surg Oncol (2009) 1.08
The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma. Int J Oncol (2004) 1.07
Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer (1974) 1.07
Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid (2007) 1.05
S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Cancer (2005) 1.05
Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression. Histopathology (2005) 1.05
Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clin Endocrinol (Oxf) (1997) 1.00
Occult papillary carcinoma of the thyroid gland: a study of 140 cases observed in a 30-year period. J Clin Endocrinol Metab (1960) 1.00
Thyroglossal duct and ectopic thyroid disorders. Otolaryngol Clin North Am (1981) 1.00
Latent thyroid carcinoma in Iceland at autopsy. Pathol Res Pract (1992) 1.00
BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases. Cancer (2007) 0.98
Presence of BRAF V600E in very early stages of papillary thyroid carcinoma. Thyroid (2007) 0.98
Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol (1996) 0.98
BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management. Ann Surg Oncol (2009) 0.98
Occult papillary thyroid carcinoma in the young and the aged. Cancer (1984) 0.98
Struma cordis. Ectopic thyroid goiter in the right ventricle. Arch Pathol Lab Med (1986) 0.97
Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab (2002) 0.96
Occult papillary thyroid carcinoma in postmortem species: prevalence at autopsy. Am J Otolaryngol (2005) 0.96
Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid (2005) 0.95
Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid (2007) 0.95
Smallest forms of papillary carcinoma of the thyroid. A study of 141 microcarcinomas less than 0.1 cm in greatest dimension. Arch Pathol (1971) 0.94
Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol (2006) 0.94
S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid. Mod Pathol (2008) 0.93
Analysis of thyroid carcinoma based on material registered in Japan during 1977-1986 with special reference to predominance of papillary type. Cancer (1992) 0.93
Cancer mortality in women with thyroid disease. Cancer Res (1990) 0.92
The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer (1989) 0.92
Metastases from occult thyroid carcinoma. An autopsy study from Hiroshima and Nagasaki, Japan. Cancer (1970) 0.91
Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer. Arch Otolaryngol Head Neck Surg (2009) 0.91
Thyroid cancer in thyroglossal duct remnants: a diagnostic and therapeutic dilemma. Thyroid (2004) 0.91
The occurrence of carcinoma of the thyroid gland in autopsy material. N Engl J Med (1947) 0.89
Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Head Neck (2010) 0.89
Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis. Rheumatology (Oxford) (2009) 0.89
Metastatic struma ovarii: the burden of truth. Clin Nucl Med (2006) 0.87
The multiplicity of thyroid nodules and carcinomas. N Engl J Med (2005) 0.87
Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. Endocr Pract (2009) 0.87
Occult sclerosing carcinoma of the thyroid. Cancer (1955) 0.86
Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? Acta Oncol (2007) 0.85
Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina. Cancer (1989) 0.84
Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination. Oncology (2005) 0.83
An immunohistochemical analysis of cyclin D1, p53, and p21waf1/cip1 proteins in tumors originating from the follicular epithelium of the thyroid gland. Pathol Res Pract (2001) 0.82
Papillary microcarcinoma of the thyroid. J Surg Oncol (2007) 0.81
Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid. Expert Opin Pharmacother (2007) 0.81
Thyroid carcinoma in the Japanese in Hawaii. Arch Pathol (1971) 0.80
Graves' disease and thyroid cancer. Surgery (1986) 0.79
Papillary carcinoma of the thyroid gland. Sizes of 525 tumors found at autopsy in Hiroshima and Nagasaki. Cancer (1970) 0.78
Low level of cyclin D1 protein expression in thyroid microcarcinomas from an autopsy series. Endocrine (2005) 0.76
Benign thyroid inclusions within cervical lymph nodes: an alarming incidental finding. Aust N Z J Surg (1981) 0.76
Is total thyroidectomy the procedure of choice for papillary thyroid cancer? Nat Clin Pract Oncol (2008) 0.76
Thyroid neoplasm after central nervous system irradiation for medulloblastoma in childhood: report of two cases. Childs Nerv Syst (2009) 0.76
[Geographic differences in iodine supply in the Silesia terrain in relation to thyroid cancer risk]. Wiad Lek (2001) 0.75
9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet (1994) 1.63
Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer (1996) 1.45
Boundary element method volume conductor models for EEG source reconstruction. Clin Neurophysiol (2001) 1.26
BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic. J Endocrinol Invest (2009) 1.19
Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men. J Endocrinol Invest (2004) 1.09
Human Papilloma Virus (HPV) in head and neck region: review of literature. Acta Otorhinolaryngol Ital (2009) 1.05
Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans. Am J Physiol (1997) 1.05
Role of prophylactic central neck dissection in cN0 papillary thyroid cancer. Acta Otorhinolaryngol Ital (2009) 1.02
The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man. Exp Eye Res (1997) 1.00
A family with autosomal dominant leukodystrophy linked to 5q23.2-q23.3 without lamin B1 mutations. Eur J Neurol (2009) 0.99
Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med (1996) 0.97
Immediate revision in patients with bilateral recurrent laryngeal nerve palsy after thyroid and parathyroid surgery. How worthy is it? Acta Otorhinolaryngol Ital (2012) 0.96
Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci (1996) 0.95
Papillary carcinoma in thyroglossal duct remnants: presentation of four cases and decision procedure for prophylactic thyroid gland dissection. Oncol Rep (2000) 0.94
Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res (2006) 0.93
Prenatal diagnosis of a de novo complex chromosome rearrangement (CCR) mediated by six breakpoints, and a review of 20 prenatally ascertained CCRs. Prenat Diagn (2006) 0.92
HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis (2005) 0.92
Identification of patients at high risk for hypocalcemia after total thyroidectomy. Acta Otorhinolaryngol Ital (2011) 0.91
TSC1 and TSC2 deletions differ in size, preference for recombinatorial sequences, and location within the gene. Hum Genet (2001) 0.91
Maternal serum markers. Estimation of the risk of Down's syndrome: a prospective study. Int J Clin Lab Res (1994) 0.90
Metabolic syndrome and cardiovascular risk prediction in peripheral arterial disease. Nutr Metab Cardiovasc Dis (2009) 0.90
Oral leukoplakias: to treat or not? Oral Oncol (1997) 0.90
Parameters influencing the accuracy of the point of force application determined with piezoelectric force plates. J Biomech (1999) 0.89
Epidermal growth factor receptor--its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas. Neoplasma (2005) 0.89
Laryngeal papilloma--precancerous condition? Acta Otolaryngol Suppl (1997) 0.89
Sentinel node biopsy in head and neck cancer. Ann Surg Oncol (2001) 0.88
Laser surgery of early glottic cancer in elderly. Acta Otorhinolaryngol Ital (2010) 0.87
Management and follow-up of thyroid cancer in pregnant women. Acta Otorhinolaryngol Ital (2011) 0.87
Intra- and interobserver agreement and impact of arterial input selection in perfusion CT measurements performed in squamous cell carcinoma of the upper aerodigestive tract. AJNR Am J Neuroradiol (2009) 0.87
Role of sentinel lymph node biopsy in oral cancer. Acta Otorhinolaryngol Ital (2006) 0.85
The incorporation of thymidine into deoxyribonucleic acid in mouse fibroblasts infected with polyoma virus. Biochem J (1966) 0.85
Serum levels of IGF-I, HGF, TGFbeta1, bFGF and VEGF in thyroid gland tumors. Physiol Res (2004) 0.85
Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol (1999) 0.85
Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells. Oncogene (2012) 0.84
Exhaled NO during graded changes in inhaled oxygen in man. Thorax (1997) 0.84
Subjective functional results 1 year after surgery and postoperative radiation for oropharyngeal carcinoma. Eur Arch Otorhinolaryngol (2001) 0.83
A late onset variant of ataxia-telangiectasia with a compound heterozygous genotype, A8030G/7481insA. J Med Genet (2002) 0.83
Subcutaneous calcification in the pectoralis major flap: a late complication of radiotherapy. Br J Radiol (2011) 0.83
Schwannoma of thyroid bed. A case report and considerations on interdisciplinary collaboration. Acta Otorhinolaryngol Ital (2005) 0.82
Our surgical experience with large vestibular schwannomas. Otolaryngol Pol (2004) 0.82
Tissue heat content and distribution during and after cardiopulmonary bypass at 17 degrees C. Anesth Analg (1999) 0.82
Role of nitric oxide in hemostatic system activation in vivo in humans. Arterioscler Thromb Vasc Biol (1995) 0.82
Compartmental surgery in tongue tumours: description of a new surgical technique. Acta Otorhinolaryngol Ital (2009) 0.81
Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas? Histol Histopathol (2009) 0.81
[An unusual case of primary hyperparathyroidism in a woman with Gorlin-Goltz syndrome]. Vnitr Lek (2000) 0.81
Efficacy of two methods for reducing postbypass afterdrop. Anesthesiology (2000) 0.81
Surgical treatment strategy for thyroid gland carcinoma nodal metastases. Eur Arch Otorhinolaryngol (1997) 0.81
Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation. Int J Oncol (2001) 0.81
Thyroid cancer: possible role of telemedicine. Acta Otorhinolaryngol Ital (2008) 0.81
Early detection of cancer: ideas for a debate. Crit Rev Oncol Hematol (2006) 0.80
Nitric oxide synthase inhibition in the histamine headache model. Cephalalgia (1997) 0.80
Methemoglobinemia in pregnancy (clinical and experimental study). Acta Univ Carol Med (Praha) (1971) 0.80
Motion measurement with high-speed video. J Biomed Eng (1993) 0.79
Endogenous lectins (galectins-1 and -3) as probes to detect differentiation-dependent alterations in human squamous cell carcinomas of the oropharynx and larynx. Int J Mol Med (2000) 0.79
[The surgical approach and results of implantation of the Czech cochlear neuroprosthesis]. Cas Lek Cesk (1989) 0.79
[Current treatment strategies for papillary thyroid microcarcinoma]. HNO (2013) 0.79
The MARS questionnaire: quality of life survey for acute rhinosinusitis. B-ENT (2014) 0.79
[Nonlinear dynamics, chaos theory and wavelet analysis of the heart]. Wien Klin Wochenschr (2000) 0.78
Interleukin-20 circulating levels in obese women: effect of weight loss. Nutr Metab Cardiovasc Dis (2009) 0.78
[The vascular supply of the pectoralis major muscle]. Cesk Otolaryngol (1988) 0.78
Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation. Anesth Analg (2000) 0.78
[Mathematical models in epidemiological analysis. II. Typhoid fever: time series analysis (author's transl)]. Ann Sclavo (1981) 0.78
The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study. QJM (2008) 0.78
Timing of breast cancer surgery in relation to the menstrual cycle: an update of developments. Crit Rev Oncol Hematol (2001) 0.78
[Bacteremia in tonsillectomy: Sluder's technique versus dissection. Preliminary results]. Recenti Prog Med (2001) 0.78
Pregnancy and thyroid cancer: ultrasound study of foetal thyroid. Acta Otorhinolaryngol Ital (2009) 0.77
Effect of a multidisciplinary program of weight reduction on endothelial functions in obese women. J Endocrinol Invest (2003) 0.77
Phenotype of five cases of prenatally diagnosed campomelic dysplasia harboring novel mutations of the SOX9 gene. Ultrasound Obstet Gynecol (2010) 0.77
Comparison of Helicobacter pylori genotypes obtained from the oropharynx and stomach of the same individuals - a pilot study. Prague Med Rep (2012) 0.77
Detection of new diagnostic markers in pathology by focus on growth-regulatory endogenous lectins. The case study of galectin-7 in squamous epithelia. Prague Med Rep (2005) 0.77
[Functional evaluation of shoes for children based on gait analysis of children in the learning to walk stage]. Z Orthop Ihre Grenzgeb (1999) 0.77
Thyroid stem cells--danger or resource? Acta Otorhinolaryngol Ital (2009) 0.77
Mandible reconstruction and autogenous frozen bone graft: experimental study on rats. Microsurgery (2001) 0.77
Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice. Anticancer Res (1999) 0.77
B and T lymphocytic populations and subpopulations and natural killer cells (NK) in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance (MGUS). Pathologica (1986) 0.76
Thyroid disease in northern Italian children born around the time of the Chernobyl nuclear accident. Ann Oncol (2004) 0.76
[Biodegradation of dacron vascular prostheses. Physico-chemical, histological, morphometric and ultrastructural study]. Minerva Cardioangiol (1993) 0.76
Serum troponin T levels in adults undergoing anthracycline therapy. J Natl Cancer Inst (1997) 0.76
Platelet vitamin D receptor is reduced in osteoporotic patients. Panminerva Med (2012) 0.76
Helicobacter pylori in tonsillar and adenoid tissue and its possible role in oropharyngeal carcinogenesis. Folia Biol (Praha) (2008) 0.76
Ultrasound dye-assisted surgery (USDAS): a promising diagnostic and therapeutic tool for the treatment of cancer recurrences in the neck. Acta Otorhinolaryngol Ital (2011) 0.75
Metastasis to the right stellate ganglion and vagal nerve: pathological alterations causing sudden death. A case report. Acta Otorhinolaryngol Ital (2012) 0.75
[Inverted papillomas]. Sb Lek (1989) 0.75
[Changes in the alveolar surfactant in Mendelson's syndrome. Introductory note to the description of a clinical case]. Minerva Anestesiol (1978) 0.75
[Nature and mechanism of action of exogenous factors in chronic bronchitis]. Arch Monaldi (1979) 0.75